EVOLABIS has been founded recently with the objective of negotiating and promoting traditional and new pharmaceuticals in Brazil.

The company started its activities in June, 2002, and immediately became successful because of its portfolio with well-established products and its competent commercial network.

To let that happen, EVOLABIS obtained a license to trade a large variety of medical products from major pharmaceutical laboratories, and assumed all production, trade and distribution processes.

The company is managed by a highly qualified board of officers who have large experience in the Brazilian pharmaceutical market.

Our strategy planning aims at consolidating the existing participation in Cardiology, Rheumatology, Pediatrics, Dermatology and Oncology, and also at starting to develop new specialities.

In May, 2006 EVOLABIS obtained its first exclusive license, Gelclair, a trademark of the renowned Swiss company Helsinn.

As a result of our constant contact with renowned companies new trade licenses have already been or are about to be obtained.

:: back